Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nurexone Biologic: Jetzt diese wirklich einzigartige Chance ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3E1GW | ISIN: BE0974464977 | Ticker-Symbol: 2NF
Tradegate
26.04.24
19:06 Uhr
86,92 Euro
+0,18
+0,21 %
1-Jahres-Chart
SYENSQO SA Chart 1 Jahr
5-Tage-Chart
SYENSQO SA 5-Tage-Chart
RealtimeGeldBriefZeit
86,5486,9013:05
86,5886,9026.04.
GlobeNewswire (Europe)
401 Leser
Artikel bewerten:
(2)

Syensqo SA: Participation notification by Solvac SA.

Participation notification by Solvac SA.

Brussels, Belgium - February 19, 2024 - 8:30 CET

According to Belgian transparency legislation (Law of May 2, 2007), Solvac SA (Rue de Champs Elysées 43 - 1050 Bruxelles, Belgium) sent to Syensqo the following transparency notification indicating that it crossed the 30% regulatory threshold was exceeded. Here is a summary of the move:

Date on which the threshold was crossed Voting rights after the transaction Equivalent financial instruments after the transaction Total
December 11, 2023 30.81% - 30.81%

The notification, dated February 15, 2024, contains the following information:

  • Reason for the notification: Holding of voting securities upon first admission to trading
  • Notified by Solvac SA: A parent undertaking or a controlling person
  • Date on which the threshold is crossed: December 11, 2023
  • Threshold of direct voting rights crossed: 30% upwards
  • Denominator: 105,876,417
  • Additional information: On the basis of Solvac SA's shareholding in Solvay SA prior to the partial demerger (last notification dated March 24, 2021 relating to the crossing of a threshold on March 19, 2021), Solvac SA held 30.81% of the share capital of Solvay SA and therefore holds 30.81% of the share capital of Syensqo at the time of the partial demerger.

Transparency notifications and the full chain of controlled undertakings through which the holding is effectively held is available on the Investor Relations Sectionof Syensqo's website.

Contacts

Media relationsInvestor relations
Nathalie van Ypersele
+32 478 20 10 62

Perrine Marchal
+32 478 32 62 72

Laetitia Schreiber
+32 487 74 38 07



media.relations@syensqo.com (mailto:media.relations@syensqo.com)
Sherief Bakr
+ 44 7920 575 989

Bisser Alexandrov
+33 607 635 280

Imtiyaz Lokhandwala
+1 609 860 3959

investor.relations@syensqo.com (mailto:investor.relations@syensqo.com)


About Syensqo

Syensqo is a science company developing groundbreaking solutions that enhance the way we live, work, travel and play. Inspired by the scientific councils which Ernest Solvay initiated in 1911, we bring great minds together to push the limits of science and innovation for the benefit of our customers, with a diverse, global team of more than 13,000 associates.

Our solutions contribute to safer, cleaner, and more sustainable products found in homes, food and consumer goods, planes, cars, batteries, smart devices and health care applications. Our innovation power enables us to deliver on the ambition of a circular economy and explore breakthrough technologies that advance humanity.

Attachments

  • Copy of Solvac Syensqo tr-1be-fr (5) SB 150224 signed (https://ml-eu.globenewswire.com/Resource/Download/de45e30f-3192-4588-94d6-77087ab44726)
  • 20240219_ TresholdNotification_EN (https://ml-eu.globenewswire.com/Resource/Download/3c22b669-1d29-4089-a811-9b5db916e7a8)

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2024 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.